Principal Investigator
Bradley Gampel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240529
Clinical Trial Summary
A PHASE I/IIA STUDY OF 2-HYDROXYOLEIC ACID IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA AND OTHER ADVANCED SOLID TUMORS
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647